Use of Nanotechnology in Diagnosis and Treatment of Hepatic Fibrosis: A Review

Author(s): Somayeh Taymouri, Azade Taheri

Journal Name: Current Drug Delivery

Volume 13 , Issue 5 , 2016


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Liver fibrosis is an important cause of morbidity and mortality worldwide and represent a difficult clinical challenge of global importance. The liver fibrosis progression needs to be controlled because persisted liver fibrosis can lead to liver cirrhosis or even hepatocellular carcinoma. Despite significant advances in the understanding of the liver fibrosis development, the therapeutic effect of drugs used in liver fibrosis treatment is not sufficient. Today, nanotechnology has been considered as a potential tool for developing novel drug delivery systems for the improved imaging and various diseases, including liver fibrosis. In this article, we discussed the use of nanotechnology for the treatment and imaging of liver fibrosis.

Keywords: Antifibrotic therapy, antiviral therapy, hepatic stellate cells, liver fibrosis, nanotechnology, siRNA.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 5
Year: 2016
Published on: 24 June, 2016
Page: [662 - 672]
Pages: 11
DOI: 10.2174/1567201812666150907115404
Price: $65

Article Metrics

PDF: 52
HTML: 4